Sequana Medical NV received premarket approval from the U.S. FDA for its Alfapump system to treat recurrent or refractory ascites due to liver cirrhosis. Data from the Poseidon pivotal study showed ...
NEW YORK, Dec. 3, 2024 /PRNewswire/ -- Martin Pharmaceuticals, a clinical-stage pharmaceutical company developing CIQUAAX® (docarpamine) for the treatment of complications arising from advanced liver ...
Can-Fite BioPharma (CANF) announced that a patient treated with Namodenoson has reached an overall survival of 9 years to date with complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback